Pacific Biosciences of California(PACB)

搜索文档
Pacific Biosciences of California(PACB) - 2021 Q4 - Earnings Call Transcript
2022-02-16 10:24
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2021 Earnings Conference Call February 15, 2022 4:30 PM ET Company Participants Todd Friedman - Director, IR Christian Henry - President, CEO & Director Susan Kim - CFO Mark Van Oene - COO Conference Call Participants Kyle Mikson - Canaccord Genuity Tejas Savant - Morgan Stanley Tycho Peterson - JPMorgan Chase Daniel Brennan - Cowen and Company Ross Osborn - Cantor Fitzgerald Operator Good day, and thank you for standing by. Welcome to the Pacific Bio ...
Pacific Biosciences of California (PACB) Presents at 40th Annual Healthcare Virtual conference - Slideshow
2022-01-16 05:18
| --- | --- | |--------------------------------------------------------------------------------------------------------------------|-------| | | | | Transforming PacBio 40th Annual J.P. Morgan Healthcare Christian Henry \| President and Chief Executive Officer | | 1 For research use only. Not for use in diagnostic procedures. © 2022 PacBio. All rights reserved. PacBio, the PacBio logo, SMRT, SMRTbell, Iso-Seq, and Sequel are trademarks of PacBio. All other trademarks are the sole property of their respectiv ...
Pacific Biosciences of California (PACB) presents at 2021 Virtual Healthcare Conference
2021-11-24 02:27
1 STIFEL 2021 VIRTUAL HEALTHCARE CONFERENCE SUSAN KIM, CFO © 2021 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ALL RIGHTS RESERVED. PACIFIC BIOSCIENCES SAFE HARBOR STATEMENT All statements in this presentation (and any accompanying oral presentation) that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or ou ...
Pacific Biosciences of California(PACB) - 2021 Q3 - Quarterly Report
2021-11-05 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (St ...
Pacific Biosciences of California(PACB) - 2021 Q3 - Earnings Call Transcript
2021-11-03 12:53
Call Start: 16:30 January 1, 0000 5:34 PM ET New Pacific Biosciences of California (NASDAQ:PACB) Q3 2021 Earnings Conference Call November 2, 2021 16:30 ET Company Participants Todd Friedman - Director of Investor Relations Christian Henry - President, Chief Executive Officer & Director Susan Kim - Chief Financial Officer Mark Van Oene - Chief Operating Officer Conference Call Participants Tycho Peterson - JPMorgan Chase Kyle Mikson - Canaccord Genuity Tejas Savant - Morgan Stanley Dan Brennan - Cowen & Com ...
Pacific Biosciences of California (PACB) Presents At 2021 Wells Fargo Virtual Healthcare Conference
2021-10-02 03:42
1 WELLS FARGO HEALTHCARE CONFERENCE SUSAN KIM, CFO © 2021 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ALL RIGHTS RESERVED. PACIFIC BIOSCIENCES SAFE HARBOR STATEMENT All statements in this presentation (and any accompanying oral presentation) that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future ...
Pacific Biosciences of California(PACB) - 2021 Q2 - Quarterly Report
2021-08-06 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (State o ...
Pacific Biosciences of California(PACB) - 2021 Q2 - Earnings Call Transcript
2021-08-04 11:07
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Todd Friedman - Director, IR Christian Henry - President, CEO & Director Susan Kim - CFO Mark Van Oene - COO Conference Call Participants Tycho Peterson - JPMorgan Chase & Co. Tejas Savant - Morgan Stanley Poon Mah - Piper Sandler & Co. Kyle Mikson - Canaccord Genuity Operator Good afternoon, ladies and gentlemen, and welcome to the Pacific Biosciences of California, Inc. Sec ...
Pacific Biosciences of California (PACB) Presents At BofA Securities 2021 Virtual Health Care Conference - Slideshow
2021-05-29 03:05
For Research Use Only. Not for use in diagnostic procedures. © Copyright 2021 by Pacific Biosciences of California, Inc. All rights reserved. BofA Securities 2021 Virtual Health Care Conference Christian Henry President & Chief Executive Officer For Research Use Only. Not for use in diagnostic procedures. © Copyright 2021 by Pacific Biosciences of California, Inc. All rights reserved. | --- | --- | |------------------------------------------------------------------------------------------------------------- ...
Pacific Biosciences of California(PACB) - 2021 Q1 - Quarterly Report
2021-05-06 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (State ...